Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers.
Morris
J C
JC
Department of Neurology, Washington University, St. Louis, Missouri, USA.
Farlow
M R
MR
Ferris
S H
SH
Kurz
A F
AF
Maelicke
A
A
Rasmusen
L
L
Wilkinson
D
D
Yan
B
B
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans
D002800:Cholinesterase Inhibitors; D005702:Galantamine